ZAI LAB LIMITED Deposits Assets, Noncurrent
ZAI LAB LIMITED (ZLAB) had Deposits Assets, Noncurrent of $1.28 million as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DepositsAssetsNoncurrent · last filed 2025-02-27
- 2024-12-31: Deposits Assets, Noncurrent $1.28M.
- 2024-09-30: Deposits Assets, Noncurrent $975.00K.
- 2024-06-30: Deposits Assets, Noncurrent $1.44M.
- 2024-03-31: Deposits Assets, Noncurrent $1.48M.
| Period end | Deposits Assets, Noncurrent | Deposits Assets, Noncurrent as first filed |
|---|---|---|
| 2024-12-31 | $1.28M 10-K · filed 2025-02-27 | |
| 2024-09-30 | $975.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.44M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $1.48M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.21M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $1.26M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.58M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $1.32M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.40M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $1.33M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $947.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $941.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $870.00K 10-K · filed 2023-03-01 | |
| 2021-09-30 | $901.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $891.00K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $910.00K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $862.00K 10-K · filed 2022-03-01 | |
| 2020-06-30 | $712.00K 6-K · filed 2020-09-11 | |
| 2019-12-31 | $377.00K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $443.05K 6-K · filed 2020-01-21 | |
| 2018-12-31 | $557.00K 20-F · filed 2020-04-29 | $556.74K 20-F · filed 2019-03-29 |
| 2017-12-31 | $306.82K 20-F · filed 2019-03-29 | |
| 2016-12-31 | $267.98K 20-F · filed 2018-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |